Neurotech Solutions, Ltd. Launches MOXO Analytics Tests To Evaluate ADHD : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

Neurotech Solutions, Ltd. Launches MOXO Analytics Tests To Evaluate ADHD

March 10, 2014

Neurotech Solutions, Ltd. Launches MOXO Analytics Tests To  Evaluate ADHD
Online ADHD Test for accurate ADHD Assessment

Science Park, Nes Zional Israel (RPRN) 03/10/14 — MOXO Analytics is officially announced as an innovative online, science-based and clinically validated system for ADHD analysis.

- Minimizing the cost and inconvenience of diagnosing Attention Deficit Hyperactivity Disorder (ADHD) an innovative platform from Neurotech Solutions, Inc. is announced to help professionals make a difference in the field.  Having launched their MOXO Analytics platform Neurotech sets about to support professionals as they work to help the 7.5 percent of school-age children affected by the disorder.  Offering an inventive answer for the many children and adults who still remain undiagnosed MOXO Analytics offers comprehensive resources and two ADHD online assessment tests.

The MOXO Analytics ADHD online test offers two versions – the 14-minute children's test for ages 7 to 12 and the 18-minute adult's test for ages 13 and above.   With the use of a computerized d-CPT, that serves as an objective tool to evaluate a patient’s attentiveness, the Neurotech MOXO Analytics platform uses distracter systems to simulate the daily environment of participants.  It then uses a distinctive clinical system to deliver comprehensive and measurable indices regarding developmental, cognitive and behavioral components.  From there its objectively generated data optimizes the process of diagnosing and treating the disorder while reducing expenses.  Simply stated, it produces results within weeks instead of months. 

The culmination of years of research the platform is recognized as an “objective decision-support tool” and is the only clinical system of its kind.  Giving numeric data to compare the scores of patients both before and after treatment MOXO takes diagnosis all the way through to therapy.  Adva Peled Levie, VP of Marketing and Sales at Neurotech Solutions, Ltd. said of MOXO Analytics, “We’ve worked hard to create an online testing tool that’s both convenient and comprehensive for helping clinicians diagnose and treat ADHD.  Our interface is user-friendly and approachable and we’re very careful to maximize the privacy of our participants by using HIPAA standards.”

About Neurotech Solutions, Ltd.:

Neurotech Solutions Ltd. is a startup company that develops cutting-edge

Internet-based software technologies. The company's efforts are focused on research, evaluation, and improvement of human cognition and behavior with a special emphasis on Attention-Deficit/Hyperactivity Disorder (ADHD). 

For more information visit www.moxo-adhdtest.com.  

Media Contact Name: Ella Shelly
Media E-mail:
Media Phone: +972-8-6466107
Media Web Address: www.moxo-adhdtest.com
Click here to see all news from this author/company

Filed Under: BREAKING NEWS, Technology, EDUCATION, PRESS RELEASE, Israel

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Zikto taking award-winning Arki to Startup Nations Summit

Seoul, Korea 11/22/14 · Zikto taking award-winning Arki to Startup Nations Summit The...

The End of Transparency? Don't be a fraud target

Carrollton, TX 11/18/14 · - Over the years, progressive and productive societies...

Ultraseal international in finals of Midlands Business Awards 2015

Coventry, UK 11/14/14 · Ultraseal International, which exports to the automotive supply...

Arki: Hot New Wearable Tech Setting a Cracking Pace on Kickstarter

San Francisco, CA 11/14/14 · Update for November 21: 412 Backers $90,034 pledged...

UpWest Labs Unveils Details of Its Eighth Batch of Startups, Ranging From Genetics to 3D Design

Palo Alto, California 11/11/14 · Accelerator continues to support innovative entrepreneurs with its...

Modern Casting Impregnation helps automakers to avoid warranty claims on engines

Novi, MI 11/11/14 · Automakers can save money and avoid costly warranty...

The Evolution of Walking: Wearable Tech steps up to a new level

San Francisco, CA 11/11/14 · Arki: Finally Wearable Meets Fashion – Wearable technology is one of 2014’s...

GeneSegues Awarded $1 Million Phase II NIH/NCI Research Contract for Nanoencapsulated RNAi Cancer Therapeutic

MINNEAPOLIS, MN 11/10/14 · Highly Competitive NIH Program Validates Potential of GS-10...

More Than 400 .Onion Addresses Targeted as Part of Global Enforcement Action on Tor Network

WASHINGTON 11/07/14 · More Than 400 .Onion Addresses, Including Dozens of...

Learn about Wine in Your Pjs - A New Kind of Wine Class

SAUSALITO, CA. 11/04/14 · The Wine Key announced today it's first virtual...

XCEL Professional Services Has Made a Huge Change to Move Our Company Forward

Calgary, AB 11/04/14 · Introducing Rob Hay: The New President of XCEL...

Furries and Despair – two-man show at Canessa Gallery, November 7 Wild is beautiful

San Francisco, CA 11/03/14 · The show  "Furries and Despair" at Canessa Gallery...

Ristech Completes Acquisition of Kirtas Technologies Inc.

Victor, NY. 11/03/14 · With the acquisition of Kirtas Technology, Ristech increases...

Signed, sealed, delivered: Email best practices

San Francisco, CA 10/31/14 · Email is the original Web app. Born in...